Satsuma Pharmaceuticals, Inc.
STSA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $28,822 | $131,285 | $80,240 | $115,403 |
| - Cash | $16,429 | $15,835 | $36,326 | $22,755 |
| + Debt | $138 | $1,080 | $3,032 | $4,930 |
| Enterprise Value | $12,531 | $116,530 | $46,946 | $97,578 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$58,313 | -$50,616 | -$46,098 | -$26,505 |
| % Margin | – | – | – | – |
| Net Income | -$69,163 | -$51,264 | -$47,674 | -$28,515 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.16 | -1.76 | -2.74 | -4.86 |
| % Growth | -22.7% | 35.8% | 43.6% | – |
| Operating Cash Flow | -$51,516 | -$42,997 | -$42,327 | -$29,637 |
| Capital Expenditures | -$472 | -$2,030 | -$5,165 | -$551 |
| Free Cash Flow | -$51,988 | -$45,027 | -$47,492 | -$30,188 |